Early and Long-Term Outcomes After Manual and Remote Magnetic Navigation Guided Ventricular Tachycardia Ablation

2017 ◽  
Vol 26 ◽  
pp. S179
Author(s):  
P. Qian ◽  
K. Da Silva ◽  
S. Kumar ◽  
R. Kurup ◽  
F. Nadri ◽  
...  
EP Europace ◽  
2018 ◽  
Vol 20 (suppl_2) ◽  
pp. ii11-ii21 ◽  
Author(s):  
Pierre Qian ◽  
Kasun De Silva ◽  
Saurabh Kumar ◽  
Fazlur Nadri ◽  
Rahul Samanta ◽  
...  

2015 ◽  
Vol 4 (3) ◽  
pp. 177 ◽  
Author(s):  
Jackson J Liang ◽  
Pasquale Santangeli ◽  
David J Callans ◽  
◽  
◽  
...  

Ventricular tachycardia (VT) often occurs in the setting of structural heart disease and can affect patients with ischaemic or nonischaemic cardiomyopathies. Implantable cardioverter-defibrillators (ICDs) provide mortality benefit and are therefore indicated for secondary prevention in patients with sustained VT, but they do not reduce arrhythmia burden. ICD shocks are associated with increased morbidity and mortality, and antiarrhythmic medications are often used to prevent recurrent episodes. Catheter ablation is an effective treatment option for patients with VT in the setting of structural heart disease and, when successful, can reduce the number of ICD shocks. However, whether VT ablation results in a mortality benefit remains unclear. We aim to review the long-term outcomes in patients with different types of structural heart disease treated with VT ablation.


2020 ◽  
Vol 315 ◽  
pp. 36-44
Author(s):  
Anna Maria Elisabeth Noten ◽  
Astrid Armanda Hendriks ◽  
Sing-Chien Yap ◽  
Daniel Mol ◽  
Rohit Bhagwandien ◽  
...  

2015 ◽  
Vol 43 (2) ◽  
pp. 187-192 ◽  
Author(s):  
Sung-Hwan Kim ◽  
Yong-Seog Oh ◽  
Dong-Hwi Kim ◽  
Ik Jun Choi ◽  
Tae-Seok Kim ◽  
...  

Author(s):  
Andres Enriquez ◽  
Jackson Liang ◽  
Jeffrey Smietana ◽  
Daniele Muser ◽  
Pablo Salazar ◽  
...  

Background - Truncating variants of the titin gene (TTNtv) are a leading cause of dilated cardiomyopathy (DCM) and have been associated with an increased risk of ventricular arrhythmias. This study evaluated the substrate distribution and the acute and long-term outcomes of patients with TTN-related cardiomyopathy undergoing ventricular tachycardia (VT) ablation. Methods - This multicenter registry included 15 patients with DCM (age 59±11 years, 93% male, ejection fraction 30±12%) and genotypically confirmed TTNtvs who underwent VT ablation between July 2014 and July 2020. Results - All patients presented with sustained monomorphic VT, including electrical storm in 4 of them. A median of 2 VTs per patient were induced during the procedure (cycle-length 318±68 ms) and the predominant morphologies were left bundle branch block with inferior axis (39%) and right bundle branch block with inferior axis (29%). A complete map of the left ventricle (LV) was created in 12 patients and showed voltage abnormalities mainly at the periaortic (92%) and basal septal region (58%). A preprocedural cardiac magnetic resonance imaging was available in 13 patients and in 11 there was evidence of LV delayed gadolinium enhancement, with predominantly midmyocardial distribution. Sequential ablation from both sides of the septum was required in 47% of patients to target septal intramural substrate and epicardial ablation was performed in 20%. At the end of the procedure, the clinical VT was noninducible in all patients, while in 3 cases a non-clinical VT was still inducible. After a follow-up of 26.5±23.0 months, 53% of patients experienced VT recurrence, 20% received transplant or mechanical circulatory support and 7% died. Conclusion - The arrhythmogenic substrate in TTN-related cardiomyopathy involves the basal septal and perivalvular regions. Long-term outcomes of catheter ablation are modest, with high recurrence rate, likely related to an intramural location of VT circuits.


Sign in / Sign up

Export Citation Format

Share Document